Phylogix, Inc. and Large Scale Biology Corporation have formed a bioprocessing alliance to develop and manufacture Phylogix, Inc.’s lead therapeutic protein, a native protein in hyacinth seeds called FRIL. The protein represents a novel chemoprotective agent that, in animals, has demonstrated a unique ability to protect normal tissues from the toxic side effects of chemotherapy. Read more about LSBC And Phylogix Form Bioprocessing Alliance[…]